The Future of Agriculture
Welcome to the Future of Agriculture and learn how biotechnology and agriculture are helping to shape the way for a sustainable future.
Bovine plasma donors genetically engineered to produce human antibodies are in the front lines of the struggle against coronavirus.
SAB Biotherapeutics, a Sioux Falls, S.D., biotechnology company that has been successfully testing use of antibodies from cows to fight diseases such as another coronavirus, Middle East respiratory syndrome, now is engaged in developing a treatment for COVID-19, the disease caused by the novel coronavirus.
SYRACUSE, N.Y. (AP) — Chestnuts harvested from high branches on a chilly fall morning look typical: they’re marble sized, russet colored and nestled in prickly burs. But many are like no other nuts in nature.
In a feat of genetic engineering, about half the chestnuts collected at this college experiment station feature a gene that provides resistance to blight that virtually wiped out the American chestnut tree generations ago.
For centuries, physicians have been controlling human diseases using all the tools available to them: proper nutrition of patients, sanitation, early disease diagnosis and intervention through medicines, including those derived from natural sources, chemicals and with more recent innovations, such as gene editing.
Likewise, farmers also control plant and animal diseases using the same approaches — proper plant and animal nutrition, sanitation, early disease diagnosis and intervention through natural, chemical and genetic sources.